Earnings calendar/TSHA
Taysha Gene Therapies, Inc. (TSHA)
Pre-earnings consensus targets and post-earnings beat/miss — standardized metrics from the earnings calendar. No narrative, no price targets.
Pre-earnings
Consensus targets for the next print, plus how the business has been running.
Next report
Nov 3, 2026
Consensus estimate row
EPS target
$-0.14
Street estimate
Revenue target
$755,556
Street estimate
Trailing EPS (avg 4Q)
$-0.11
Beat rate last 4: 50%
Latest EPS YoY
-44.4%
vs 2025-08-12
Latest revenue YoY
—
How results look so far
Trailing revenue (avg 4Q)
$5.5M
Printed quarters
EPS beat rate (4Q)
50%
Share of quarters that beat EPS est.
Post-earnings
Did the company hit the target? Actual vs estimate and surprise.
Last print
Aug 11, 2026
EPS miss
EPS actual / est
$-0.13 / $-0.11
-14.7%
Revenue actual / est
— / $680,000
—
Result
Below target
Based on EPS vs consensus
Earnings history
Estimate vs actual and surprise % by print date
| Date | EPS est | EPS act | EPS surprise | Rev est | Rev act | Rev surprise |
|---|---|---|---|---|---|---|
| 11/3/2026upcoming | $-0.14 | Pending | — | $755,556 | Pending | — |
| 8/11/2026 | $-0.11 | $-0.13 | -14.7% | $680,000 | Pending | — |
| 5/21/2026upcoming | $-0.10 | Pending | — | $850,000 | Pending | — |
| 5/6/2026 | $-0.10 | $-0.12 | -20.0% | $755,556 | Pending | — |
| 3/19/2026 | $-0.11 | $-0.08 | +27.3% | $2.2M | $5.5M | +144.5% |
| 3/18/2026upcoming | $-0.09 | Pending | — | $1.9M | Pending | — |
| 3/11/2026upcoming | $-0.09 | Pending | — | $1.9M | Pending | — |
| 3/4/2026upcoming | $-0.11 | Pending | — | $1.9M | Pending | — |
| 2/25/2026upcoming | $-0.11 | Pending | — | $2.1M | Pending | — |
| 11/4/2025 | $-0.09 | $-0.09 | 0.0% | $1.9M | Pending | — |
| 8/12/2025 | $-0.07 | $-0.09 | -28.6% | $1.7M | $2.0M | +14.9% |
| 5/15/2025 | $-0.08 | $-0.08 | 0.0% | $1.1M | $2.3M | +112.3% |
| 2/26/2025 | $-0.08 | $-0.07 | +12.5% | $2.1M | $2.0M | -1.5% |
| 11/13/2024 | $-0.08 | $-0.09 | -12.5% | $2.1M | $1.8M | -12.9% |
| 8/12/2024 | $-0.10 | $-0.09 | +10.0% | $2.7M | $1.1M | -58.2% |
| 5/14/2024 | $-0.11 | $-0.10 | +9.1% | $2.6M | $3.4M | +33.2% |
| 3/19/2024 | $-0.09 | $0.35 | +488.9% | $2.6M | $3.6M | +36.0% |
| 11/14/2023 | $-0.17 | $-0.13 | +23.5% | $2.3M | $4.7M | +103.5% |
| 8/14/2023 | $-0.31 | $-0.38 | -22.6% | $1.1M | $2.4M | +128.1% |
| 5/11/2023 | $-0.35 | $-0.28 | +20.0% | $70,000 | $4.7M | +6622.9% |
| 3/28/2023 | $-0.41 | $-0.99 | -141.5% | $8.2M | $2.5M | -69.4% |
| 11/8/2022 | $-0.89 | $-0.64 | +28.1% | — | Pending | — |
| 8/11/2022 | $-1.05 | $-0.84 | +20.0% | — | Pending | — |
| 5/16/2022 | $-1.04 | $-1.31 | -26.0% | — | Pending | — |
| 3/31/2022 | $-1.21 | $-1.32 | -9.1% | — | Pending | — |
| 11/10/2021 | $-1.02 | $-1.35 | -32.4% | — | Pending | — |
| 8/16/2021 | $-0.81 | $-1.09 | -34.6% | — | Pending | — |
| 5/11/2021 | $-0.54 | $-0.87 | -61.1% | — | Pending | — |
| 3/3/2021 | $-0.37 | $-1.04 | -181.1% | — | Pending | — |
| 11/12/2020 | $-0.17 | $-1.28 | -652.9% | — | Pending | — |
| 9/25/2020 | — | $-0.09 | — | — | Pending | — |
| 6/30/2020 | — | $-0.15 | — | — | Pending | — |
| 12/31/2019 | — | $-0.02 | — | — | Pending | — |